SMS Lifesciences India informs about outcome of board meeting

10 Nov 2025 Evaluate

SMS Lifesciences India has informed that the Board of Directors of the Company at its Meeting held today, November 10, 2025, have considered and approved the unaudited [Standalone & Consolidated] financial results for the quarter and half year ended September 30, 2025, as recommended by the Audit Committee. In this regard, the company has enclosed a copy of the following: 1) Unaudited financial results (Standalone & Consolidated) for the quarter and half year ended September 30,2025, along with limited review report. 2) Statement of Assets & Liabilities and Cash-flow statement. 3) Related Party Transactions for the half year ended September 30, 2025. The meeting of the Board commenced at 02.45 pm and concluded at 4.15 pm.

The above information is a part of company’s filings submitted to BSE.

Haleos Labs Share Price

1224.15 -61.65 (-4.79%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×